Douglas Reed MD

Douglas Reed MD is a declared insider at 2 companies; the most frequent names are Digirad Corp and Tetralogic Pharmaceuticals Corp. In total, 24 filings cover trades dated from 29 April 2005 to 17 December 2013.

The open-market side counts 1 purchase for €727k alongside 10 sales for €479k. Taken together, the purchases exceed the sales by €248k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant. 2013 to date brings 1 purchase and no sales.

On 19 December 2013 came the latest disclosure, an open-market purchase for €727k in Tetralogic Pharmaceuticals Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.